Business Description
Emyria Limited is an Australian healthcare company focused on improving outcomes for people living with mental health conditions such as PTSD and treatment-resistant depression. Through its Pax Centre facility, it delivers specialist psychological care while also advancing a pipeline of drug candidates, including purified CBD capsules and novel MDMA-based compounds. The company works alongside the University of Western Australia to strengthen its drug development efforts and has been operating under its current name since 2020, following its founding in 2018 in Leederville, Western Australia.
